Dose-ranging study of OPC-41061 in patients with cardiac edema (congestive heart failure: CHF)
Phase 2
- Conditions
- Cardiac edema (CHF)
- Registration Number
- JPRN-jRCT2080220038
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
CHF patients with edema, jugular venous distention, hepatomegaly, pulmonary congestion, or 3rd sound due to extracellular volume expansion despite taking oral furosemide, aged between 20 and 80 years, not inclusive, at time of consent
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, safety
- Secondary Outcome Measures
Name Time Method